In the BioHarmony Drug Report Database

"Preview" Icon

Topotecan

Hycamtin, Topotecan, Topotecan Hospira (topotecan) is a small molecule pharmaceutical. Topotecan was first approved as Hycamtin on 1996-05-28. It is used to treat non-small-cell lung carcinoma, ovarian neoplasms, small cell carcinoma, small cell lung carcinoma, and uterine cervical neoplasms in the USA. It has been approved in Europe to treat ovarian neoplasms, small cell lung carcinoma, and uterine cervical neoplasms. Topotecan hydrochloride’s patent is valid until 2024-12-10 (FDA).

 

Trade Name

 

Hycamtin, Topotecan Hospira
 

Common Name

 

topotecan
 

ChEMBL ID

 

CHEMBL84
 

Indication

 

non-small-cell lung carcinoma, ovarian neoplasms, small cell carcinoma, small cell lung carcinoma, uterine cervical neoplasms
 

Drug Class

 

Antineoplastics (camptothecine derivatives)

Image (chem structure or protein)

Topotecan structure rendering